All News InhaleRx Limited

Equities

IRX

AU0000179475

Market Closed - Australian S.E. Other stock markets 02:10:19 2024-05-24 EDT			5-day change	1st Jan Change
0.03 ^AUD	-25.00%		-.--%	+3.45%

05-30	InhalerX Files Investigational New Drug Application with US FDA for Drug-Device Pain Medication	MT
03-28	InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

InhalerX Files Investigational New Drug Application with US FDA for Drug-Device Pain Medication	05-30	MT
InhaleRx Limited announced that it expects to receive AUD 0.5 million in funding from Peak Asset Management, LLC	03-27	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2023	02-13	CI
InhaleRx to Focus on Breakthrough Cancer Pain for Phase 2 Trial of Cannabinoid Analgesic	01-10	MT
InhaleRx Secures Nearly AU$550,000 R&D tax Incentive Prepayment	12-21	MT
InhaleRX Completes Phase One Trial for Pain Medication Device	12-04	MT
InhaleRx Files Ethics Application for Panic Disorder Trial	23-10-17	MT
InhaleRx Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21	CI
InhaleRx Limited Announces Change of Registered Office Address	23-08-02	CI
InhaleRx Limited Announces Executive Changes	23-08-02	CI
InhaleRx Completes First Cohort of Phase One Clinical Trial	23-06-14	MT
Australian Shares Retreat Anew on Rate Hike, Slower-than-Expected GDP Growth	23-06-07	MT
InhaleRx Doses First Individuals for Phase One Trial of Inhalable Pain Medication	23-06-07	MT
InhaleRx Limited Auditor Raises 'Going Concern' Doubt	23-03-29	CI
InhaleRx Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-26	CI
InhaleRx Hires Contract Research Organization for Upcoming Clinical Trials	22-12-22	MT
Inhalerx Limited Announces Fda Pre-Ind Application Update	22-12-11	CI
InhaleRx Limited Announces Board and Management Changes	22-09-26	CI
InhaleRx Limited Announces the Appointment of Darryl Davies as Chief Executive Officer	22-09-26	CI
InhaleRx Raises $810,000 From Share Placement	22-09-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News InhaleRx Limited

Equities

IRX

AU0000179475

All News

Filters